We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR

This study has been withdrawn prior to enrollment.
(recruiting problems)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01179542
First Posted: August 11, 2010
Last Update Posted: September 13, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Meir Medical Center
  Purpose
The involvement of eukaryotic translation initiation factor 4E (eIF4E) in human placental implantation and in the pathological pregnancies: preeclampsia and IUGR.

Condition
Pregnancy Preeclampsia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR.

Resource links provided by NLM:


Further study details as provided by Meir Medical Center:

Primary Outcome Measures:
  • measure the Translation Initiation effect of experimental variables observational studies [ Time Frame: 2 years ]

Enrollment: 0
Study Start Date: September 2010
Study Completion Date: October 2012
Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
first trimester
first trimester
third trimester
third trimester
prgnancies complicated with IUGR
prgnancies complicated with IUGR
preeclampsia
preeclampsia

Detailed Description:
4 groups
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Only the Placenta aftr delivery or abortion
Criteria

Inclusion Criteria:

  • post TOP or DELIVERY

Exclusion Criteria:

  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Meir Medical Center
ClinicalTrials.gov Identifier: NCT01179542     History of Changes
Other Study ID Numbers: mmc10134-2010ctil
First Submitted: August 10, 2010
First Posted: August 11, 2010
Last Update Posted: September 13, 2017
Last Verified: August 2010

Keywords provided by Meir Medical Center:
iugr pet eIF4E Translation Initiation Factor
4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications